Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127692661 | 12769266 | 1 | I | 201606 | 20160913 | 20160921 | 20160921 | EXP | FR-ABBVIE-16P-056-1734363-00 | ABBVIE | 9.96 | YR | M | Y | 32.00000 | KG | 20160921 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127692661 | 12769266 | 1 | PS | ZECLAR | CLARITHROMYCIN | 1 | Unknown | Y | UNKNOWN | 50662 | |||||||||
| 127692661 | 12769266 | 2 | SS | DOLIPRANE | ACETAMINOPHEN | 1 | Oral | Y | UNKNOWN | 0 | |||||||||
| 127692661 | 12769266 | 3 | SS | PERFALGAN | ACETAMINOPHEN | 1 | Intravenous (not otherwise specified) | Y | UNKNOWN | 0 | |||||||||
| 127692661 | 12769266 | 4 | SS | AUGMENTIN | AMOXICILLINCLAVULANATE POTASSIUM | 1 | Intravenous (not otherwise specified) | Y | UNKNOWN | 0 | |||||||||
| 127692661 | 12769266 | 5 | SS | CIFLOX | CIPROFLOXACIN | 1 | Intravenous (not otherwise specified) | Y | UNKNOWN | 0 | |||||||||
| 127692661 | 12769266 | 6 | SS | TAZOCILLINE | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | Intravenous (not otherwise specified) | Y | UNKNOWN | 0 | |||||||||
| 127692661 | 12769266 | 7 | SS | REMICADE | INFLIXIMAB | 1 | Unknown | Y | UNKNOWN | 0 | |||||||||
| 127692661 | 12769266 | 8 | SS | FORTUM | CEFTAZIDIME | 1 | Intravenous (not otherwise specified) | Y | UNKNOWN | 0 | |||||||||
| 127692661 | 12769266 | 9 | SS | FORTUM | CEFTAZIDIME | 1 | Intravenous (not otherwise specified) | Y | UNKNOWN | 0 | |||||||||
| 127692661 | 12769266 | 10 | SS | VANCOMYCINE | VANCOMYCIN | 1 | Unknown | Y | UNKNOWN | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127692661 | 12769266 | 1 | Product used for unknown indication |
| 127692661 | 12769266 | 2 | Product used for unknown indication |
| 127692661 | 12769266 | 3 | Product used for unknown indication |
| 127692661 | 12769266 | 4 | Product used for unknown indication |
| 127692661 | 12769266 | 5 | Product used for unknown indication |
| 127692661 | 12769266 | 6 | Product used for unknown indication |
| 127692661 | 12769266 | 7 | Product used for unknown indication |
| 127692661 | 12769266 | 8 | Product used for unknown indication |
| 127692661 | 12769266 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127692661 | 12769266 | LT |
| 127692661 | 12769266 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127692661 | 12769266 | Cell death | |
| 127692661 | 12769266 | Cholestasis | |
| 127692661 | 12769266 | Eosinophilia | |
| 127692661 | 12769266 | Hyperbilirubinaemia | |
| 127692661 | 12769266 | Prothrombin time shortened |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127692661 | 12769266 | 1 | 20160711 | 0 | ||
| 127692661 | 12769266 | 2 | 20160624 | 20160625 | 0 | |
| 127692661 | 12769266 | 3 | 20160626 | 20160630 | 0 | |
| 127692661 | 12769266 | 4 | 20160626 | 20160628 | 0 | |
| 127692661 | 12769266 | 5 | 20160627 | 20160703 | 0 | |
| 127692661 | 12769266 | 6 | 20160629 | 20160703 | 0 | |
| 127692661 | 12769266 | 7 | 20160628 | 20160628 | 0 | |
| 127692661 | 12769266 | 8 | 20160710 | 20160715 | 0 | |
| 127692661 | 12769266 | 9 | 20160717 | 20160718 | 0 | |
| 127692661 | 12769266 | 10 | 20160707 | 20160725 | 0 |